Bellevue Group AG engages in the asset management business in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid-caps, and private equity strategies; and multi asset and bond solutions. The company was founded in 1993 and is headquartered in Zurich, Switzerland.
Frequently asked questions
What sector does Bellevue Group AG (BBN) operate in?
Bellevue Group AG belongs to the Financials sector and operates in the Asset Management industry.
What is Bellevue Group AG (BBN) current stock price?
As of the latest data, Bellevue Group AG stock price is CHF 7.34, with a previous close of CHF 7.26. Bellevue Group AG gained CHF 0.08 in the last trading session, representing a 1.1% increase.
What is Bellevue Group AG (BBN) current market capitalization?
Bellevue Group AG market cap is approximately 97.78 million.
What is Bellevue Group AG (BBN) Earnings Per Share (EPS)?
The trailing EPS is CHF 0.26, and the forward EPS is CHF 1.09.
What is Bellevue Group AG (BBN) Price-to-Earnings (P/E) ratio?
Bellevue Group AG current P/E ratio is 28.23, with a forward P/E of 6.73.
What is Bellevue Group AG (BBN) EBITDA?
Bellevue Group AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 4.20 million.
Does Bellevue Group AG (BBN) pay dividends?
Yes. Bellevue Group AG pays annual dividends with an annualized yield of 2.04% and an estimated annual payout of CHF 0.15 per share.
When is the next ex-dividend date for Bellevue Group AG (BBN)?
The next ex-dividend date is scheduled for March 26, 2027.
What is Bellevue Group AG (BBN) beta (volatility) score?
Bellevue Group AG has a beta of 0.870, meaning its volatility is roughly in line with the market.
